©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Acid Stabilization of Plasminogen Activator Inhibitor-1 Depends on Protonation of a Single Group That Affects Loop Insertion into -Sheet A (*)

(Received for publication, May 23, 1995; and in revised form, August 31, 1995)

Jan-Olov Kvassman (1)(§) Daniel A. Lawrence (2) Joseph D. Shore (1)

From the  (1)Henry Ford Health Sciences Center, Division of Biochemical Research, Detroit, Michigan 48202-3450 and the (2)American Red Cross, Department of Biochemistry, Rockville, Maryland 20855

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

The serpin plasminogen activator inhibitor-1 (PAI-1) spontaneously adopts an inactive or latent conformation by inserting the N-terminal part of the reactive center loop as strand 4 into the major beta-sheet (sheet A). To examine factors that may regulate reactive loop insertion in PAI-1, we determined the inactivation rate of the inhibitor in the pH range 4.5-13. Below pH 9, inactivation led primarily to latent PAI-1, and one predominant effect of pH on the corresponding rate constant could be observed. Protonation of a group exhibiting a pK of 7.6 (25 °C, ionic strength = 0.15 M) reduced the rate of formation of latent PAI-1 by a factor of 35, from 0.17 h at pH 9 to about 0.005 h below pH 6. The ionization with a pK 7.6 was found to have no effect on the rate by which PAI-1 inhibits trypsin and is therefore unlikely to change the flexibility of the loop or the orientation of the reactive center. The peptides Ac-TEASSSTA and Ac-TVASSSTA (cf. P14-P7 in the reactive loop of PAI-1) formed stable complexes with PAI-1 and converted the inhibitor to a substrate for tissue type plasminogen activator. We found that peptide binding and formation of latent PAI-1 are mutually exclusive events, similarly affected by the pK 7.6 ionization. This is direct evidence that external peptides can substitute for strand 4 in beta-sheet A of PAI-1 and that the pK 7.6 ionization regulates insertion of complementary, internal or external, strands into this position. A model that accounts for the observed pH effects is presented, and the identity of the ionizing group is discussed based on the structure of latent PAI-1. The group is tentatively identified as His-143 in helix F, located on top of sheet A.


INTRODUCTION

Plasminogen activator inhibitor, PAI-1, is a member of the serpin family of serine proteinase inhibitors and inhibits both tPA (^1)and urokinase plasminogen activator (1, 2) as well as trypsin(3) . The serpins(4) , which include most of the inhibitors that regulate blood coagulation and fibrinolysis, are structurally homogenous and are distinguished functionally from other types of protein proteinase inhibitors primarily by the ability to form SDS-stable complexes with target proteinases. The nature of these complexes and the mechanism by which they are formed are poorly understood.

Active serpins are metastable folding intermediates with considerable conformational strain(5) . They can relax by inserting the N-terminal portion of the reactive center loop as strand 4 in the major beta-sheet that faces one side of the protein (sheet A) and thereby adopt an inactive, or latent, conformation. This process occurs spontaneously in PAI-1 (6) and has been induced in antithrombin III (5) and alpha(1)-proteinase inhibitor(7) . Inhibitory serpins attain an even greater stability after cleavage of the reactive loop, near or at the susceptible bond, and insertion of the N-terminal portion into beta-sheet A (8, 9, 10) or after forming complexes with peptides that mimic this part of the loop(11, 12) . The fact that serpins with a completed six-stranded sheet A are inactive (13) clearly indicates a role for loop insertion in the inhibitory mechanism. Data obtained for alpha(1)-proteinase inhibitor in complex with N-terminal truncated strand 4A-mimicking peptides were taken to indicate that insertion of the loop into sheet A down to residue P14 (notation according to Schechter and Berger(14) ) is necessary and sufficient for inhibition of trypsin by this serpin(11) . The concept presented was that with such limited insertion the loop adopts a more rigid conformation akin to that of the loop in Kunitz type inhibitors. The consequences of this view are that inhibition is due to tight binding and that the bound inhibitor can only be cleaved slowly. The bound reactive center may approach formation of a tetrahedral intermediate, which could account for the NMR data presented by Travis et al.(15) . Evidence for a fast insertion of the loop region containing residue P9 upon formation of the tPAbulletPAI-1 complex was recently obtained in our laboratory from studies of a PAI-1 mutant with a fluorescent probe on P9(16) , and the idea was put forward that cleavage of the reactive bond may be required to trigger such a fast, extensive insertion of the loop. This, on the other hand, is difficult to reconcile with dissociation of proteinase-serpin complexes into active enzymes and inhibitors(17) .

Although the fate of the susceptible bond in the proteinase-serpin complex remains obscure, it has been well established that in order for serpins to be fully active they must possess a potential for unhindered insertion of part of the reactive center loop into beta-sheet A(11, 12, 18, 19, 20) . Consequently, studies of loop insertion leading to latent PAI-1 and factors that affect this process may yield significant insights into the mechanism of serpin inhibition. Several studies (21, 22, 23) have shown that one such factor is pH and that the transformation of active PAI-1 to latent is much slower at weakly acidic rather than at physiological pH values. The present investigation was initiated to characterize this pH effect and the associated proton dissociation equilibrium or equilibria.


EXPERIMENTAL PROCEDURES

Reagents

Gel filtration columns (PD-10) were from Pharmacia (Uppsala, Sweden), and TSK-DEAE was from Merck Pharmaceutical Company (Darmstadt, Germany). Materials for SDS-PAGE and activated agarose were from Bio-Rad Laboratories (Hercules, California). N-acetylated peptides were synthesized by the University of Michigan Protein Facility (Ann Arbor, Michigan) and provided as lyophilized free acids. H-D-isoleucyl-L-prolyl-L-arginine-p-nitroaniline was obtained from Chromogenix (Mölndal, Sweden), and p-nitrophenyl p-guanidinobenzoate was from Sigma. Buffers were prepared from analytical grade chemicals using deionized, distilled, and degassed water.

Proteins

Human recombinant PAI-1, expressed in Escherichia coli, was a generous gift from Dr. David Ginsburg (Howard Hughes Medical Institute, Ann Arbor, Michigan) and was supplied as a frozen bacterial lysate(24) . The inhibitor was purified and separated into the active and latent components by chromatography on heparin and phenyl-substituted Sepharose by a method previously developed by two of us and described elsewhere(25) . The concentration of active PAI-1 was determined spectrophotometrically at 280 nm using the extinction coefficient 0.93 ml mg(26) and a molecular weight of 43,000. Trypsin from bovine pancreas (N-tosyl-phenylalanine chlormethyl ketone-treated), bovine basic pancreatic trypsin inhibitor, BPTI (Aprotinin), and soybean trypsin inhibitor were from Sigma. The pancreatic inhibitor was dissolved in 0.15 M NaCl, and its concentration was determined spectrophotometrically at 280 nm in a pH 7.4 buffer using an extinction coefficient of 0.84 ml mg and a molecular weight of 6513(27) . The soybean inhibitor was immobilized to activated agarose, according to the instructions provided by the manufacturer of the gel. Trypsin was further purified by affinity chromatography on the immobilized soybean trypsin inhibitor, essentially as described in (28) . The alpha- and beta-trypsin fractions were precipitated by dialysis in the cold against solid ammonium sulfate, corresponding to 90% saturation at equilibrium, and stored as suspensions in the cold. Only beta-trypsin was used in this study, and its active site concentration was determined by titration with p-nitrophenyl p-guanidinobenzoate(29) . Upon use, aliquots of trypsin were withdrawn from the suspension and collected by centrifugation. Stock solutions were prepared by dissolving the precipitate in 1 mM HCl. Activase, the tPA, was a kind gift from Dr. Bruce Keyt (Genentech Inc., San Francisco, CA). It was dissolved in water to give a tPA concentration of 3.2 mg ml and was used without further treatment. The coordinate set for latent PAI-1 was generously provided by Dr. Elizabeth Goldsmith (University of Texas Southwestern Medical Center, Dallas, TX).

General Experimental Conditions

Incubations of PAI-1 to measure its stability or reaction with peptides were performed at 25 °C in solutions containing 1 mM EDTA, 0.025 M NaOH, and one of the following buffer substances: acetic acid (pH 4.5-5.5), MES (pH 6-7), HEPES (pH 7-8), Bicine (pH 8-9), CHES (pH 8.5-9.5), or CAPS (pH 10-11). For pH values of 11 and above, 0.01-0.1 M NaOH was used. All solutions were adjusted to 0.15 M ionic strength with NaCl. Gel electrophoreses were performed under nonreducing conditions in 12 or 9% polyacrylamide gels and in the presence of 0.1% SDS (SDS-PAGE). Typically, samples for SDS-PAGE were prepared by mixing aliquots of 4-5 µM PAI-1 with a 2-3-fold molar excess tPA at pH 7-8, which were then incubated for about 5 min. The developed gels were stained with Coomassie Blue.

Quantitative Analysis of Gels

Transmission images of stained gels were taken with a video camera, and the gray scale intensity of each pixel was converted to absorbance. An estimate of the relative amount of protein in a band on the gel was obtained by summation of the pixel absorbances within the band after subtracting the background absorbance.

Spontaneous Inactivation of PAI-1

The rate constant for inactivation of PAI-1 as a function of pH was determined by incubating 5 µM active inhibitor in buffers ranging in pH from 4.5-13. Aliquots were withdrawn at timed intervals and assayed for active PAI-1. For this purpose, tPA was added to cuvettes with 0.1 mMH-D-isoleucyl-L-prolyl-L-arginine-p-nitroaniline in a pH 7.4 HEPES buffer, and the amidolytic activity was monitored spectrophotometrically at 405 nm. The aliquot with PAI-1 was added, and its content of active inhibitor was calculated from the resulting decrease in tPA activity. The residual concentration of active inhibitor in the incubation vials was plotted against time, and the rate constant for inactivation was evaluated for each pH by fitting a first order decay function to the data. To ensure that the reduction with time in PAI-1 activity was not caused by adsorption or precipitation, selected incubation vials (0.2 ml) were centrifuged for 5 min at 10^4 times g, and the resulting supernatants were treated with excess tPA and analyzed by SDS-PAGE.

Characterization of Inactive PAI-1

Partially or completely inactive PAI-1 was generated by incubation of the inhibitor at pH 6, 9, and 11. A fourth sample of PAI-1 was completely inactivated at pH 8.2 and then incubated at pH 11 for 4 h. Following incubation, the samples were desalted on a PD-10 column, equilibrated with 0.15 M ionic strength sodium phosphate buffer at pH 7.0, diluted to 10-20 µg of PAI-1 ml, and degassed. The solutions were heated at a rate of about 2 °C/min in the thermostatted cell holder of a Shimadzu RF540 fluorescence spectrophotometer. Both monochromators were set to 330 nm, and the intensity of the scattered light was measured at pre-set temperatures in the range of 25-80 °C. A stainless steel coated thermocouple, immersed in the sample, served as a thermometer.

Effects of pH on PAI-1 Reactivity

beta-Trypsin (6 nM) was reacted with the chromogenic substrate H-D-isoleucyl-L-prolyl-L-arginine-p-nitroaniline (0.2 mM) in the presence of PAI-1 (0.1-0.3 µM) or BPTI (1-3 µM) at pH 6.0, 7.0, and 8.1, respectively, and the resulting absorbance changes at 405 nm were recorded. The pseudo first order rate constant for inhibition of beta-trypsin by respective inhibitor was determined by nonlinear least squares analysis of the exponential progress curves.

Peptide-induced Inactivation of PAI-1

Stock solutions of Ac-TVASSSTA (1 mM) and Ac-TEASSSTA (10 mM) were prepared in 0.14 and 0.11 M NaCl solutions, respectively, and neutralized with NaOH. To compare the effect of pH on peptide binding and formation of latent PAI-1, 4-5 µM of the active inhibitor was incubated with and without 0.2 mM Ac-TVASSSTA or 1 mM Ac-TEASSSTA in buffers ranging in pH from 4.5 to 11. Aliquots of the incubation mixtures were treated with excess tPA and analyzed by SDS-PAGE. Because the PAI-1bulletpeptide complexes were completely cleaved by tPA, the proportion of cleaved to latent PAI-1, determined from the bands on the gels, were taken as a measure of the ratio of peptide-bound to latent PAI-1 established prior to treatment with tPA. The effect of peptide concentration on this ratio was determined at pH 7 and 8 for Ac-TVASSSTA and at 7.4 for Ac-TEASSSTA by the same technique. For this purpose, 4-5 µM active PAI-1 was incubated with peptide ranging in concentration from 0.02-0.2 mM Ac-TVASSSTA or 0.2-2.0 mM Ac-TEASSSTA and analyzed by SDS-PAGE, after complete inactivation of PAI-1. The stability of the PAI-1 complex with Ac-TEASSSTA was assessed by incubating fully active PAI-1 for 2 days at pH 7.4 at room temperature with 1 mM of the peptide. Excess peptide was removed by gel filtration, and the complex was subjected to continuous dialysis for several days. Aliquots of the dialysate were withdrawn at timed intervals, treated with excess tPA, and analyzed by SDS-PAGE for a change of the quotient between latent and cleaved PAI-1.

Effects of pH on PAI-1 Fluorescence

Emission spectra of active and latent PAI-1, as well as of a mixture of PAI-1 in complex with Ac-TVASSSTA and latent PAI-1, were recorded at 25 °C with a Shimadzu RF540 fluorescence spectrophotometer. The excitation wavelength was set to 280 nm. The protein concentrations were adjusted to 0.5 µM (active PAI-1) or 0.05 µM (latent and peptide bound PAI-1) in buffers ranging in pH from 5 to 10.


RESULTS

Spontaneous Inactivation of PAI-1

Inactivation of PAI-1 was first order for the complete time course in the pH range 6-13. At pH 5 and below, the stability of the active inhibitor makes it difficult to follow the inactivation to completion, and data obtained in this pH interval were assumed to reflect a monophasic first order inactivation process. Rate constants for inactivation of pure active PAI-1, obtained between pH 4.5 and 13, are shown in Fig. 1. Two major effects of pH on the inactivation process can be seen in the investigated interval. Below pH 9 the rate constant for formation of inactive PAI-1 depends on the ionic state of a single group in the inhibitor with an apparent pK(a) of 7.6. Protonation of this group reduces the rate of inactivation of PAI from 0.17 h at pH 9 to 0.005 h at pH 5 and below and is thus linked to stabilizing interactions corresponding to about 2 kcal mol. Heat denaturation of partially and completely inactive PAI-1, generated at pH 6.0 and 9.4, respectively (Fig. 2), monitored by light scattering (24) indicated that latent PAI is the major product of inactivation in this pH interval. The second effect of pH on the inactivation process becomes evident at pH 11 and above, where the rate constant for inactivation of PAI-1 increases in proportion to the OH ion. As shown in Fig. 2, PAI-1 inactivated at pH 11 for 2 h scatters more light at lower temperatures than active or latent PAI-1 and exhibits less distinct changes in light scattering when heated, consistent with formation of a different, denatured species at high pH. PAI-1 inactivated at pH 8.2 and exposed to pH 11 for 4 h (corresponding to 6 half-lives of active PAI-1 at the latter pH) retains the thermostability characteristic of latent PAI-1. This justifies the interpretation of the inactivation data presented in Fig. 1as resulting from two practically irreversible processes, one leading to latent PAI-1 and the other, which is induced by alkaline pH and insignificant in the neutral pH range, to denaturation.


Figure 1: Effects of pH on the rate constant for inactivation of PAI-1. Data were obtained kinetically (circle) or by SDS-PAGE () as described under ``Experimental Procedures.'' The inset shows data obtained in the alkaline pH range. The solid line represents the equation

with the best fit parameter values k(max) = 0.167 h, k = 1132 h, pK(6) = 6.041, and pK(7) = 7.58.




Figure 2: Thermostability analysis of PAI-1. Measurements were performed as described under ``Experimental Procedures.'' Samples of PAI-1 were prepared by incubation of the inhibitor at pH 6 for 16 h (1), pH 9.4 for 6 h (2), pH 10.9 for 2 h (3), and at pH 8.2 for 36 h followed by pH 10.9 for 4 h (4).



Effect of pH on PAI-1 Reactivity

Effects of the pK(a) 7.6 ionization on the reactive center in PAI-1 was investigated by comparing the rates of inhibition of beta-trypsin by PAI-1 and BPTI in the pH range 6.0-8.1. Because the same solution of enzyme and substrate was used to test both inhibitors and the reactions were first order in inhibitor concentration, the ratio between the second order rate constants for inhibitor binding, k/k, could be calculated from the observed rate constants and the inhibitor concentrations using , derived from expressions presented in (30) .

where C(X) stands for the total concentration of X. The ratio in will vary with pH only if the hydrogen ion has different effects on the reactivity of the two inhibitors. The values obtained for k/k at pH 6.0, 7.0, and 8.1, were 5.7, 6.3, and 6.3 respectively.

Peptide-induced Inactivation of PAI-1

If the free peptides substitute for strand 4 in beta-sheet A, peptide binding to PAI-1 must occur in strict competition with formation of the latent form of the inhibitor. This relationship is illustrated by Fig. S1. With peptide in large excess, equilibration of the system in Fig. S1will be governed by two exponential transients, the first reflecting formation of latent PAI-1 and the PAI-1bulletpeptide complex in kinetic competition, and the second reflecting the subsequent relaxation of the system in favor of the thermodynamically most stable species. However, when mixtures of PAI-1 and peptide were analyzed by electrophoresis, no change with time in the proportion of latent to cleaved PAI-1 could be detected even after removal of free peptide by dialysis. Consequently, on the time scale of the first transient, the second will not be observed, and the system in Fig. S1will be characterized by a single exponential decay of active PAI-1 according to .


Figure S1: Scheme 1.



where the 0 and t subscripts denote the concentration of active PAI-1 at reaction time 0 and t, respectively, and the time constant (r(1)) is given by

The laws of probability then predict that in the process of inactivation, latent and peptide-bound PAI-1 are formed according to and , respectively.

It follows from and that the ratio of peptide-bound to latent PAI-1 (R) at any time during the reaction, should be given by

To test the validity of , PAI-1 was incubated with various concentrations of peptide, and the proportion of cleaved to latent inhibitor was determined for each concentration by quantitative analysis of gels, such as the one demonstrated in Fig. 3. The results are shown in Fig. 4(A and B). The linear dependence of R on peptide concentration, established for both peptides, is consistent with and confirms that peptide binding and formation of the latent inhibitor are competitive events. The small intercepts observed result from cleavage of some PAI-1 by tPA in the absence of peptides (Fig. 3, lane 0). The slopes of the regression lines in Fig. 4B, representing k/k for Ac-TVASSSTA at pH 7.0 and 8.1, are 16 and 20 mM, respectively. If peptide association (k), in contrast to reactive loop folding (k), were pH-independent, these slopes should have differed by a factor of 4. The single line in Fig. 4A was obtained for the association of Ac-TEASSSTA at pH 7.4 and has a slope of 1.0 mM. Using the best fit estimates of k (the solid line in Fig. 1), k for Ac-TVASSSTA evaluates to 0.18 and 0.74 M s at pH 7.0 and 8.1, respectively, whereas a value of 0.020 M s is obtained for Ac-TEASSSTA at pH 7.4. The effect of pH on R can be seen in Fig. 5and 6. The gel shown in Fig. 5confirms the pH effects on the rate of formation of inactive PAI-1 reported above and indicates in a qualitative way that the proportion of peptide-bound to latent PAI-1 does not vary much with pH and, consequently, that reactive loop folding and peptide binding exhibit a similar dependence on pH. This is quantitatively confirmed by the data presented in Fig. 6obtained by analysis of the gel in Fig. 5and by the data obtained from similar gels developed for both peptides (not shown).


Figure 3: Effect of peptide concentration on the proportion of peptide-bound (cleaved) to latent PAI-1 demonstrated by SDS-PAGE. PAI-1 (4 µM) was incubated for 5 days at pH 7.4 and 25 °C with increasing concentrations of Ac-TEASSSTA and analyzed by treatment with excess tPA followed by SDS-PAGE.




Figure 4: Quantitative evaluation of the effect of peptide concentration on the proportion of peptide-bound (cleaved) to latent PAI-1. The ratio of cleaved to latent PAI-1, generated by incubation of the active inhibitor with Ac-TEASSSTA (A) at pH 7.4 and Ac-TVASSSTA (B) at pH 7.0 (bullet) and pH 8.1 (circle), was determined from gels like the one shown in Fig. 3and plotted versus peptide concentration.




Figure 5: Effects of pH on the ratio of peptide bound (cleaved) to latent PAI-1 demonstrated by SDS-PAGE. PAI-1 (5 µM) was incubated at 25 °C with (+) and without(-) 1 mM Ac-TEASSSTA in buffers ranging in pH from 4.6 to 10.6.




Figure 6: Quantitative evaluation of the effect of pH on the proportion of latent to peptide bound (cleaved) PAI-1. The proportion of latent to cleaved inhibitor, generated after incubation of the active inhibitor with Ac-TEASSSTA for 6 (circle) and 22 h (bullet) were determined from gels like the one shown in Fig. 5. The dotted line is the proportion expected if peptide association leading to cleaved PAI-1 were pH-independent.



Effects of pH on PAI-1 Fluorescence Emission

Emission spectra of active PAI-1 obtained at pH 6.0 and 9.3 are shown in Fig. 7. The major difference, observed at the peak of the two spectra, results from a quench of the fluorescence in the 310-350 nm region when pH is raised from 6 to 7. A smaller effect of pH is seen above 350 nm as a gradual increase in emission intensity when pH is raised from 6 to 9. The insert in Fig. 6shows that the pH-induced fluorescence changes averaged over the 380-400 nm region adhere to a proton dissociation function with a pK(a) of 7.6. Emission spectra of latent PAI-1, alone or in combination with an excess Ac-TVASSSTA-bound PAI-1, show no detectable dependence of pH in the region above 350 nm (data not shown).


Figure 7: Effects of pH on PAI-1 fluorescence. The emission spectra were recorded for active PAI-1 at pH 6.0 (solid line) and 9.4 (dotted line) as described under ``Experimental Procedures.'' The inset shows how the average emission intensity in the 380-400 nm region increases with pH; the line represents a protonic dissociation function with a pK(A) of 7.6. Fluorescence units are arbitrary and the Y axis of the inset corresponds to 0.025 such units.




DISCUSSION

By a systematic study of the effects of pH on the inactivation rate of PAI-1, we have linked the observed acid stabilization of the active form of this serpin to protonation of a single functional group in the protein. To examine whether the protonated form of the group stabilizes an exposed reactive loop in a direct manner or indirectly by preventing its binding to sheet A, the reactivity of PAI-1 and BPTI toward trypsin was compared in the pH interval over which the rate of loop insertion, leading to latent PAI-1, exhibits a 15-fold increase. The comparison of the two inhibitors' rates of reaction with trypsin was performed to mask the well known effects of pH on the active site of serine proteinases and to avoid the possible complication of exosite interactions believed to be involved in formation of the tPAbulletPAI-1 complex(31) . The absence of a significant effect of pH on the quotient between the rate constants for inhibition of trypsin by PAI-1 and BPTI in the range tested indicates that ionization of the pK(a) 7.6 group has no direct influence on the flexibility of the loop or the exposure of the reactive center in PAI-1. The alternative explanation, that the reactivity of BPTI is controlled by an internal ionization that balances the effects of that in PAI-1, lacks support in the vast literature on BPTI(32) . The most plausible explanation is therefore that the protonated form of the group stabilizes the active inhibitor by lowering the affinity of a specific binding site in PAI-1 for the latent reactive center loop.

Peptides with sequences that match the N-terminal portions of the reactive loops in alpha(1)-proteinase inhibitor (11) and antithrombin III (12) form strong complexes with the respective inhibitor and convert them to substrates for their target proteinases. It has generally been assumed that this results from binding of the peptides to the vacant crevice for strand 4A. Bound in this position, the peptides would prevent insertion of the reactive loop believed to be necessary for the inhibitory function of the serpin. Recent publications on the structure of antithrombin (33, 34) show that this serpin has a potential for peptide binding also to beta-sheet C, which indicates that the effects of peptide binding to serpins must be interpreted with caution. The present investigation, however, establishes that at least one binding site for Ac-TVASSSTA and Ac-TEASSSTA in active PAI-1 is occupied by the loop in latent PAI-1 and, hence, must be located outside beta-sheet C(6) . The crevice for strand 4 in sheet A is the only subsite for the latent loop that has the structural and chemical complementarity to the octamer peptides required to account for the strength of the PAI-1-peptide interactions. The observation that loop insertion leading to latent PAI-1 and peptide insertion are equally affected by the pK(a) 7.6 ionization must therefore be interpreted as an effect of the latter on the access of peptides to sheet A. Direct stabilization of an extended reactive center loop by the protonated form of the group would have resulted in a decreased competition for the strand 4A crevice at low pH and reverted or abolished the pK(a)-7.6 effect on association of external peptides. In summary, we conclude that the octamer loop analogs used in this study substitute for strand 4A in PAI-1 and that the pK(a) 7.6 ionization regulates binding of external and internal peptides to this position.

Electrostatic repulsion cannot account for the observed effect of pH on association of the negatively charged octamer peptides (rather, electrostatic attraction could explain the slightly less pronounced effect of pH, demonstrated in Fig. 4B and Fig. 6, on peptide association compared with loop refolding). Our interpretation is that the data presented in Fig. 1reflect a proton dissociation equilibrium in PAI-1 linked to the equilibrium between an open (I(o)) and a closed (I(c)) form of the inhibitor. The equilibrium constant K(1) is the ratio of open to closed inhibitor when the group is protonated, whereas K(3) is the ratio when the group is unprotonated; K(4) is the acid dissociation constant for the fully interacting functional group, whereas K(2) is the constant for the noninteracting group (Fig. S2). The protonated form of the group takes part in an interaction that stabilizes the closed form of the inhibitor (K(3) > K(1)). The interaction results in a reciprocal decrease in the acid dissociation constant of the functional group from K(2) to K(4). The limiting concentrations of the open form are given by


Figure S2: Scheme 2.



where C(I) is the total concentration of active inhibitor. Let k be the intrinsic rate constant for loop insertion in the open inhibitor, and the observed rate constant will be given by

From the data presented in Fig. 1, we have [I(o)](max)/[I(o)](min) = k/k = 35. In view of and , this means that K(1) < 1/34 and K(1) K(3). The actual position of these equilibria will determine the relationship between K(2) and K(4) in Fig. S1and the experimentally found constants, K(6) and K(7), presented in Fig. 1. Clearly, pK(6) corresponds to the pH at which [I(o)] approx 2 times [I(o)](min). Hence

which, with K(1) 1, simplifies to

Because

the value reported for pK(6) in Fig. 1(6.0) must be a close estimate of pK(2), the pK(a) of the noninteracting ionizing group.

A pK(a) of 6 is consistent with that of a histidine residue slightly perturbed by a hydrophobic environment or a neighboring positive charge. In the search for a candidate among the 13 histidine residues of human PAI-1, we studied the structure of the latent inhibitor and focused on histidine residues that could have a direct effect on binding of peptides to sheet A. This approach is justified by the fact that apart from the reactive center loop, the differences between serpins with 5 or 6 strands in sheet A are predominantly observed in this sheet (33, 34, 35) and its immediate vicinity. More profound changes may accompany formation of latent PAI-1 (6) but are not likely to be required for insertion of the octamer peptides. One possible candidate then is His-143 in helix F. Helix F is part of a loop that connects strand 1A and strand 3A and covers the lower half of sheet A in all inhibitory serpins. It appears that the loop containing helix F must move out of the way in order for the reactive loop to insert completely as strand 4A and that factors that stabilize the helix should slow down the insertion. In the latent inhibitor the presumably neutral His-143 (the crystals were grown at pH 8.2(36) ) is seen at hydrogen bond distance to the -oxygen of Thr-142 and the carbonyl oxygen of Trp-139, both in helix F. In the active inhibitor, a positive charge on the histidine in addition to structural differences may allow the imidazolium ring to rotate into a different position, where it may stabilize helix F by neutralizing its dipole field or by forming a hydrogen bond to sheet A. Although there is no suitable acceptor within distance for the latter bond in latent PAI-1, it can be seen from the differences between latent PAI-1 and nonrelaxed serpins (35) that sheet A in the former has expanded in the region beneath helix F. In the active inhibitor the side chain oxygen of Thr-94 in strand 2A and one of the nitrogens of His-143 may very well be within hydrogen bond distance. The spatial relationships pertinent to this discussion are illustrated by the stereodiagram of the alpha-carbon backbone of sheet A and helix F in latent PAI-1 presented in Fig. 8. The side chains of Trp-139 and His-143 in helix F and Thr-94 in strand 2A are displayed. The sequence of strand 4A, which corresponds to the octamer peptides used in this study, is represented by the heavy portion of the strand.


Figure 8: Stereodiagram of latent PAI-1. Side view of the alpha-carbon backbone of sheet A and helix F in latent PAI-1. The residues displayed are Trp-139 and His-143 in helix F and Thr-94 in strand 2A. The sequence of strand 4A homologous to the octamer peptides used in this study with P14 at the top of the sheet and helix F are marked by heavy lines.



The identity of the pK(a) 7.6 group as His-143 seems consistent with the fluorescence data presented in Fig. 7. The side chain of His-143 is within a distance of 4 Å to the indole ring of Trp-139 in latent PAI-1, half that between any other His/Trp pair in the inhibitor. A general stabilization of the sheet A/helix F region in latent and peptide-bound PAI-1, making it less sensitive to the ionic state of His-143, may explain the absence of pH effects on the red side of the emission spectrum of these species.

PAI-1 is the only serpin known to spontaneously fold its reactive center loop to adopt a latent conformation at room temperature. Among the 37 serpins listed by Marshall(37) , PAI-1 and bovine PAI-2 are the only ones with a histidine residue at position 143 in helix F, and human PAI-1 is unique in having a threonine at 94 in strand 2A. In fact, 34 of the listed serpins have either glycine or an aliphatic residue at the latter position. This combination of side chains in PAI-1, which places polar groups in the hydrophobic helix F/sheet A interface, may contribute to a more open sheet A in this serpin compared with that of others and at the same time provide means for pH regulation of the propensity of sheet A to bind strand 4. Regardless of the underlying mechanism, we may speculate about the in vivo significance of the pH-dependent stability of the active inhibitor. The study by Lindahl et al.(21) suggests that the ionic properties of the stabilizing group and its effect on active PA1-1 are maintained at 37 °C. This means that active PAI-1 basically should be about 2.5 times more stable in cells (pH = 6.8) than in plasma (pH = 7.4). Obstructions to blood flow through active tissues could lead to a local acidification through accumulation of CO(2) followed by a shift of intermediary metabolism toward fermentation with a concomitant prolongation of the lifetime of active PAI-1.


FOOTNOTES

*
This work was supported by National Institutes of Health Grant HL 45930 (to J. D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom the correspondence should be addressed. Henry Ford Health Sciences Center, Div. of Biochemical Research, One Ford Place, Detroit, MI 48202-3450. Tel.: 313-876-7291; Fax: 313-876-2380.

(^1)
The abbreviations used are: tPA, tissue type plasminogen activator; PAI-1, plasminogen activator inhibitor-1; BPTI, bovine basic pancreatic trypsin inhibitor; PAGE, polyacrylamide gel electrophoresis; MES, 4-morpholineethanesulfonic acid; Bicine, N,N-bis(2-hydroxyethyl)glycine; CHES, 2-(cyclohexylamino)ethanesulfonic acid; CAPS, 3-(cyclohexylamino)propanesulfonic acid.


REFERENCES

  1. Ny, T., Lawrence, D., Millan, J. L., and Loskutoff, D. J. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 6776-6780 [Abstract]
  2. Hekman, C. M., and Loskutoff, D. J. (1985) J. Biol. Chem. 260, 11581-11587 [Abstract/Free Full Text]
  3. Hekman, C. M., and Loskutoff, D. J. (1988) Biochemistry 27, 2911-2918 [Medline] [Order article via Infotrieve]
  4. Carrell, R. W., and Boswell, D. R. (1986) in Proteinase Inhibitors (Barrett, A. J., and Salvesen, G., eds) pp. 403-418, Elsevier Science Publishers B.V., Amsterdam
  5. Carrell, R. W., Evans, D. L., and Stein, P. E. (1991) Nature 353, 576-578 [CrossRef][Medline] [Order article via Infotrieve]
  6. Mottonen, J., Strand, A., Symersky, J., Sweet, R., Danley, D. E., Geoghegan, K., Gerard, R. D., and Goldsmith, E. J. (1992) Nature 355, 270-273 [CrossRef][Medline] [Order article via Infotrieve]
  7. Lomas, D. A., Elliott, P. R., Chang, W.-S. W., Wardell, M. R., and Carrell, R. W. (1995) J. Biol. Chem. 270, 5282-5288 [Abstract/Free Full Text]
  8. Carrell, R. W., and Owen, M. C. (1985) Nature 317, 730-732 [Medline] [Order article via Infotrieve]
  9. Gettins, P., and Harten, B. (1988) Biochemistry 27, 3634-3639 [Medline] [Order article via Infotrieve]
  10. Bruch, M., Weiss, V., and Engel, J. (1988) J. Biol. Chem. 263, 16626-16630 [Abstract/Free Full Text]
  11. Schulze, A. J., Baumann, U., Knof, S., Jaeger, S., Huber, R., and Laurell, C.-B. (1990) Eur. J. Biochem. 194, 51-56 [Abstract]
  12. Björk, I., Ylinenjärvi, K., Olson, S. T., and Bock, P. E. (1992) J. Biol. Chem. 267, 1976-1982 [Abstract/Free Full Text]
  13. Gettins, P., Patston, P. A., and Schapira, M. (1993) Bioessays 15, 461-467 [Medline] [Order article via Infotrieve]
  14. Schechter, I., and Berger, A. (1967) Biochem. Biophys. Res. Commun. 27, 157-162 [Medline] [Order article via Infotrieve]
  15. Matheson, N. R., van Halbeek, H., and Travis, J. (1991) J. Biol. Chem. 266, 13489-13491 [Abstract/Free Full Text]
  16. Shore, J. D., Day, D. E., Francis-Chmura, A. M., Verhamme, I., Kvassman, J., Lawrence, D. A., and Ginsburg, D. (1994) J. Biol. Chem. 270, 5395-5398 [Abstract/Free Full Text]
  17. Shieh, B.-H., Potempa, J., and Travis, J. (1989) J. Biol. Chem. 264, 13420-13423 [Abstract/Free Full Text]
  18. Schulze, A. J., Huber, R., Degryse, E., Speck, D., and Bishoff, R. (1991) Eur. J. Biochem. 202, 1147-1155 [Abstract]
  19. Lawrence, D. A., Olson, S. T., Palaniappan, S., and Ginsburg, D. (1994) J. Biol. Chem. 269, 27657-27662 [Abstract/Free Full Text]
  20. Hood, D. B., Huntington, J. A., and Gettins, P. G. W. (1994) Biochemistry 33, 8538-8547 [Medline] [Order article via Infotrieve]
  21. Lindahl, T. L., Sigurdardottir, O., and Wiman, B. (1989) Thromb. Haemostasis 62, 27-30
  22. Sancho, E., Tonge, D. W., Hockney, R. C., and Booth, N. A. (1994) Eur. J. Biochem. 224, 125-134 [Abstract]
  23. Kvassman, J., and Lawrence, D. (1993) Thromb. Haemostasis 69, 1328
  24. Lawrence, D., Strandberg, L., Grundström, T., and Ny, T. (1989) Eur. J. Biochem. 186, 523-533 [Abstract]
  25. Kvassman, J., and Shore., J. D. (1995) Fibrinolysis 9, 215-221
  26. Vaughan, D. E., Declerck, P. J., Reilly, T. M., Park, K., Collen, D., and Fasman, G. D. (1993) Biochim. Biophys. Acta 1202, 221-229 [Medline] [Order article via Infotrieve]
  27. Kassel, B. (1970) Methods Enzymol. 19, 844-852
  28. Yung, B. Y., and Trobridge, C. G. (1975) Biochem. Biophys. Res. Commun. 65, 927-930 [Medline] [Order article via Infotrieve]
  29. Chase, T., Jr., and Shaw, E. (1970) Methods Enzymol. 19, 20-27
  30. Liu, W., and Tsou, C. (1986) Biochim. Biophys. Acta 870, 185-190 [Medline] [Order article via Infotrieve]
  31. Chmielewska, J., Rånby, M., and Wiman, B. (1988) Biochem. J. 251, 327-332 [Medline] [Order article via Infotrieve]
  32. Bode, W., and Huber, R. (1992) Eur. J. Biochem. 204, 433-451 [Abstract]
  33. Schreuder, H. A., deBoer, B., Dijkema, R., Mulders, J., Theunissen, H. J. M., Grootenhuis, P. D. J., and Hol, W. G. J. (1994) Structural Biol. 1, 48-54
  34. Carrell, R. W., Stein, P. E., Fermi, G., and Wardell, M. R. (1994) Structure 2, 257-270 [Abstract]
  35. Goldsmith, E. J., and Mottonen, J. (1994) Structure 2, 241-244 [Medline] [Order article via Infotrieve]
  36. Goldsmith, E. J., Sheng-Cheng, C., Danley, D. E., Gerard, R. D., Geoghegan, K. F., Mottonen, J., and Strand, A. (1991) Proteins Struct. Funct. Genet. 9, 225-227 [Medline] [Order article via Infotrieve]
  37. Marshall, C. J. (1993) Philos. Trans. R. Soc. Lond. B Biol. Sci. 342, 101-119 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.